Algert Global’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-69,354
| Closed | -$809K | – | 1287 |
|
|
2024
Q4 | $809K | Buy |
69,354
+8,312
| +14% | +$97K | 0.02% | 828 |
|
|
2024
Q3 | $1.25M | Sell |
61,042
-7,330
| -11% | -$151K | 0.03% | 705 |
|
|
2024
Q2 | $1.53M | Buy |
68,372
+51,572
| +307% | +$1.15M | 0.05% | 553 |
|
|
2024
Q1 | $462K | Buy |
16,800
+2,100
| +14% | +$57.8K | 0.02% | 783 |
|
|
2023
Q4 | $448K | Buy |
+14,700
| New | +$448K | 0.02% | 854 |
|
|
2023
Q2 | – | Sell |
-23,610
| Closed | -$880K | – | 1201 |
|
|
2023
Q1 | $880K | Buy |
+23,610
| New | +$880K | 0.04% | 679 |
|
|
2022
Q3 | – | Sell |
-14,653
| Closed | -$758K | – | 1274 |
|
|
2022
Q2 | $758K | Buy |
14,653
+10,970
| +298% | +$567K | 0.06% | 590 |
|
|
2022
Q1 | $268K | Sell |
3,683
-2,745
| -43% | -$200K | 0.02% | 975 |
|
|
2021
Q4 | $760K | Sell |
6,428
-790
| -11% | -$93.4K | 0.09% | 366 |
|
|
2021
Q3 | $968K | Buy |
+7,218
| New | +$968K | 0.13% | 240 |
|